← Back to Dashboard

Patient Report - Coagulation Panel

Antiphospholipid Antibody Panel & Factor V Leiden Genetic Testing

Patient
Tyler Bishop
Date Collected
01/16/2026
Date Reported
01/22/2026
DOB
05/26/1987
Age / Sex
38 / Male
Fasting
Yes
Labcorp
Ordered Items: Antiphospholipid Antibody Panel; Factor V Leiden
Clinical Indication: Evaluation following hemarthrosis (bleeding into joint) discovered 01/04/2026
Antiphospholipid Antibody Panel

This panel tests for autoantibodies associated with antiphospholipid syndrome (APS), which can cause abnormal clotting or bleeding.

Test Result Flag Units Reference Interval
Anticardiolipin Ab, IgG, Qn <9 Negative GPL U/mL 0-14 (Negative <15)
Anticardiolipin Ab, IgM, Qn <9 Negative MPL U/mL 0-12 (Negative <13)
Anticardiolipin Ab, IgA, Qn <9 Negative APL U/mL 0-11 (Negative <12)
Beta-2 Glycoprotein I Ab, IgG <9 Negative GPI IgG units 0-20
Beta-2 Glycoprotein I Ab, IgA <9 Negative GPI IgA units 0-25
Beta-2 Glycoprotein I Ab, IgM <9 Negative GPI IgM units 0-32
Interpretation: All six antiphospholipid antibodies are negative. This rules out antiphospholipid syndrome (APS) as a cause of the hemarthrosis.
Factor V Leiden Genetic Test

Testing for the Factor V Leiden mutation (R506Q), the most common inherited cause of abnormal blood clotting.

Test Result

G-G (Normal-Normal)

No Factor V Leiden mutation present.

Interpretation: While the patient does not possess this risk factor, other thrombotic risk factors may be detected through systematic clinical laboratory analysis.

Methodology: Patient DNA was evaluated for the factor V Leiden mutation at nucleotide 1691 using allele specific PCR technology followed by gel electrophoresis.

Clinical Notes:
  • Simultaneous Risks: If a patient possesses two or more congenital or acquired thrombophilic risk factors, the risk of thrombosis may rise to more than the sum of the risk ratios for the individual risk factors.
  • The factor V Leiden mutation is an inherited characteristic. If the mutation were present, genetic counseling would be recommended.
  • This assay detects only the factor V Leiden mutation and does not detect other genetic abnormalities.
Summary: Both the Antiphospholipid Antibody Panel and Factor V Leiden genetic testing are negative. No inherited or acquired coagulopathy detected that would explain the hemarthrosis. The cause of joint bleeding remains undetermined; may require further rheumatology or hematology evaluation.

Patient Details

Bishop, Tyler

3434 VOYAGER CIR, SAN DIEGO, CA, 92130

Phone: 636-448-1747

DOB: 05/26/1987 | Age: 38 | Sex: Male

Patient ID: BT762792

Physician Details

B VEST

Dermatology Center of La Jolla

6605 Nancy Ridge Dr, San Diego, CA, 92121

Phone: 858-454-7123

Account Number: 04125132

NPI: 1891311403

Specimen Details

Specimen ID: 016-338-1981-0

Control ID: 260414VM

Date Collected: 01/16/2026 1420 Local

Date Received: 01/16/2026

Date Reported: 01/22/2026 1506 ET

Performing Labs:
01: Labcorp Phoenix, 5005 S 40th Street Ste 1200, Phoenix, AZ 85040-2969 (Anticardiolipin/Beta-2 GP)
02: Esoterix Inc, 8490 Upland Drive Ste 100, Englewood, CO 80112-7116 (Factor V Leiden)
For inquiries: 800-859-6046 | Lab: 858-668-3700